Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders

被引:101
作者
Weiss, KA
Smith, TE
Hull, JW
Piper, AC
Huppert, JD
机构
[1] Columbia Univ, Coll Phys & Surg, Dept Psychiat, Hall Brooke Behav Hlth Serv, Westport, CT 06880 USA
[2] Cornell Univ, Weill Med Coll, New York, NY USA
[3] New York Presbyterian Hosp, Schizophrenia Disorders Program, New York, NY USA
[4] Univ Penn, Philadelphia, PA 19104 USA
关键词
psychotic disorders; schizophrenia; adherence; compliance; working alliance; clozapine;
D O I
10.1093/oxfordjournals.schbul.a006943
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
We investigated the course of adherence to medication recommendations in 162 patients with psychotic disorders in ambulatory treatment. Data were collected using the clinic's outcome assessment program, maximizing the generalizability of the study. Patients initially adherent to their medication regimens maintained their adherence for an average of 13.3 months. Patients initially nonadherent developed adherence after an average of 5.6 months of treatment. Demographic factors and illness history were unrelated to adherence. This study replicated previous findings of the concurrent association between adherence and global functioning level, substance use, and working alliance with therapist. Cox regression analyses revealed that working alliance, global functioning, and being prescribed clozapine predicted longer maintenance of adherence. Working alliance was the most significant and consistent predictor of adherence to medication recommendations.
引用
收藏
页码:341 / 349
页数:9
相关论文
共 32 条
[1]   PREDICTING MEDICATION COMPLIANCE IN A PSYCHOTIC POPULATION [J].
ADAMS, SG ;
HOWE, JT .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1993, 181 (09) :558-560
[2]  
[Anonymous], 1994, Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), V4th
[3]   SUBJECTIVE RESPONSE TO ANTIPSYCHOTIC-DRUGS - FAILURE TO REPLICATE PREDICTIONS OF OUTCOME [J].
AYERS, T ;
LIBERMAN, RP ;
WALLACE, CJ .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1984, 4 (02) :89-93
[4]   REHOSPITALIZATION IN CHRONIC-SCHIZOPHRENIA [J].
CATON, CLM ;
KOH, SP ;
FLEISS, JL ;
BARROW, S ;
GOLDSTEIN, JM .
JOURNAL OF NERVOUS AND MENTAL DISEASE, 1985, 173 (03) :139-148
[5]  
CLAGHORN J, 1987, J CLIN PSYCHOPHARM, V7, P377
[6]   Interactive risk factors for treatment adherence in a chronic psychotic disorders population [J].
Corriss, DJ ;
Smith, TE ;
Hull, JW ;
Lim, RW ;
Pratt, SI ;
Romanelli, S .
PSYCHIATRY RESEARCH, 1999, 89 (03) :269-274
[7]   LONG-TERM DEPOT MAINTENANCE OF CHRONIC-SCHIZOPHRENIC OUT-PATIENTS - THE 7-YEAR FOLLOW-UP OF THE MEDICAL-RESEARCH-COUNCIL FLUPHENAZINE PLACEBO TRIAL .1. COURSE OF ILLNESS, STABILITY OF DIAGNOSIS, AND THE ROLE OF A SPECIAL MAINTENANCE CLINIC [J].
CURSON, DA ;
BARNES, TRE ;
BAMBER, RW ;
PLATT, SD ;
HIRSCH, SR ;
DUFFY, JC .
BRITISH JOURNAL OF PSYCHIATRY, 1985, 146 (MAY) :464-480
[8]  
EISEN SV, 1994, HOSP COMMUNITY PSYCH, V45, P242
[9]   Determinants of medication compliance in schizophrenia: Empirical and clinical findings [J].
Fenton, WS ;
Blyler, CR ;
Heinssen, RK .
SCHIZOPHRENIA BULLETIN, 1997, 23 (04) :637-651
[10]  
FRANK AF, 1990, ARCH GEN PSYCHIAT, V47, P228